Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Palantir Technologies enters the week with a fresh Goldman Sachs upgrade landing just as the stock pushes to $194.12, answering last week's question about whether the resilience was real.
Goldman analyst Gabriela Borges moved to Buy this morning, setting a $230 target. That is the most significant analyst development in this cycle, a bellwether firm flipping from Neutral at a price level that many had flagged as stretched. It follows a run of positive actions since the Q2 print in early August, when UBS raised its target to $220, Citigroup went to $245, and Mizuho lifted to $215. UBS has since pushed further, raising to $250 in mid-September. The direction of travel among the bulls is clear: targets have moved well above the current $194 price. The formal consensus still shows "hold" with a mean target of $185, but that reflects a stale aggregate skewed by the ten analysts sitting on the sidelines. The recent active coverage tells a different story, with Buy-rated firms clustering between $215 and $250. The bear case centres on valuation, where the PE multiple has expanded to 89x and the EV/EBITDA sits at 64x, up 8 points over the past 30 days. Cantor Fitzgerald's Neutral at $156 represents the clearest expression of the sceptical camp: the business is impressive, but the multiple leaves no margin for error.
The stock's own momentum supports the upgrade timing. PLTR has gained 3.8% on the week and 11.4% over the past month, now trading well above the $187 close from last week's note. Among correlated peers, Rubrik is the strongest performer this week at up 8.1%, and Zeta Global is up 6.9%. SoundHound is the notable laggard, down 6.5%, illustrating that the AI software trade remains stock-specific rather than a uniform tide. Palantir is outperforming the broader peer group again, as it did the previous week, which matters because that consistency has now extended long enough to look like structural demand rather than noise.
Short positioning does little to complicate the picture. Short interest is running at 2.56% of the free float, essentially flat on the week and down 12.6% over the past month, continuing the steady retreat documented in the prior note. Borrow costs remain negligible at 0.33%, and availability is at its maximum reported reading, meaning there is no scarcity in the lending market and no mechanical pressure building from the short side. The ORTEX short score of 31.1 sits in the lower third of its range, consistent with a stock where bearish positioning is modest and not intensifying.
Options positioning carries a mild hedging lean without tipping into alarm. The put/call ratio is 1.07, just above its 20-day average of 1.05, a z-score of 1.1. That is elevated relative to recent history but far from the 52-week high of 1.16. With Q3 earnings due November 2, just 25 days away, some insurance-buying in the options market is routine. The last earnings print produced a 32% next-day move and a 42% five-day return. Those numbers alone are enough to generate put demand regardless of directional view.
The institutional holder list anchors the longer-term picture. BlackRock holds 7.9% and has been adding, most recently reporting an increase of around 893,000 shares as of September 30. JP Morgan Asset Management added over 7.7 million shares in the latest reported period. Insider activity runs in the opposite direction: net selling of roughly $101 million over the past 90 days, though the transactions are predominantly small, planned 10b5-1 disposals rather than discretionary exits. Founder Peter Thiel remains a holder at 4.1% of shares as of his last filing in April, unchanged.
The Goldman upgrade is the news to track for the coming sessions, specifically whether it pulls other Hold-rated coverage firms off the fence ahead of November 2 earnings.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
